Lumen Bioscience

About:

Lumen Bio discovers, develops, and manufactures biologic drugs and vaccine candidates for various diseases.

Twitter/X: LumenBio

Top Investors: US Department of Energy, U.S. Department of Defense, Columbia Pacific Advisors, WestRiver Group, CARB-X

Description:

Lumen Bio is a clinical-stage biotechnology company developing topically and mucosally delivered biologic drugs to treat and prevent highly prevalent diseases.

Total Funding Amount:

$67M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Seattle, Washington, United States

Founded Date:

2017-04-01

Founders:

Brian Finrow, Jim Roberts

Number of Employees:

51-100

Last Funding Date:

2023-10-17

IPO Status:

Private

Industries: